Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.58 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | PPARD | Q03181 | 1/20 | 0.45 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.45 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5516547 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL3454038 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL6899785 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL25341592 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL18531126 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL23879492 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL5580131 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL571313 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL19148651 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL29209211 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117860604-A | Application of xylooligosaccharide in preparation of skin pore improving and anti-aging skin care product | 江南大学附属医院 | 2024-04-12 | — | — | CN | claimed |
| EP-3393600-B1 | SUN CARE COMPOSITION BASED ON SMALL PARTICLE O/W EMULSION | OREAL (FR) | 2024-02-21 | — | — | EP | claimed |
| CN-117547493-A | Pearl cream for maintaining beauty and keeping young and preparation method thereof | 惠州市施洛贝缇化妆品有限公司 | 2024-02-13 | — | — | CN | claimed |
| EP-4062922-B1 | EXTRACT OF SWERTIA CHIRATA AND COSMETIC COMPOSITIONS COMPRISING SAME | CHANEL PARFUMS BEAUTE (FR) | 2024-01-10 | — | — | EP | claimed |
| EP-4267077-A1 | ANHYDROUS SOLID COMPOSITION COMPRISING A MAGNESIUM SALT AND STARCH | L'OREAL (FR) | 2023-11-01 | — | — | EP | claimed |
| WO-2023102894-A1 | COMPOSITION FOR STABILIZING ACTIVE INGREDIENTS | L'OREAL (FR) | 2023-06-15 | — | — | WO | claimed |
| CN-111631976-B | Microemulsion mask liquid, microemulsion mask and preparation method of microemulsion mask liquid | 广东修身堂美容科技有限公司 | 2023-05-26 | — | — | CN | claimed |
| EP-2640789-B1 | COMPOSITIONS AND METHODS TO IMPROVE THE SETTING PROPERTIES AND RUB RESISTANCE OF PRINTING INKS | SUN CHEMICAL CORP (US) | 2023-03-01 | — | — | EP | claimed |
| EP-3393603-B1 | TOPICAL DELIVERY SYSTEM FOR ACTIVE INGREDIENTS | OREAL (FR) | 2023-01-18 | — | — | EP | claimed |
| CN-115531228-A | Cosmetic composition for improving hair containing no siloxane | UCL株式会社 | 2022-12-30 | — | — | CN | claimed |
| WO-2012068153-A1 | COMPOSITIONS AND METHODS TO IMPROVE THE SETTING PROPERTIES AND RUB RESISTANCE OF PRINTING INKS | SUN CHEMICAL CORPORATION (US) | 2012-05-24 | — | — | WO | claimed |
| US-7662470-B2 | Method and derived product, for the preparation of chips, flakes, pastes, and similar items, containing particles, to be added to moulding polymers and paints | SUPERCOLORI S.P.A. (IT) | 2010-02-16 | — | — | US | claimed |
| US-20090131542-A1 | Emulsifier Combination, Emulsion Containing the Emulsifier Combination, and a Process for its Production | COGNIS IP MANAGEMENT GMBH (DE) | 2009-05-21 | — | — | US | claimed |
| EP-1584643-A1 | Method for flatting thermoplastic polymers and paints | Supercolori S.p.A. (IT) | 2005-10-12 | — | — | EP | claimed |
| US-20050221090-A1 | Method and derived product, for the preparation of chips, flakes, pastes, and similar items, containing particles, to be added to moulding polymers and paints | SUPERCOLORI S.P.A. (IT) | 2005-10-06 | — | — | US | claimed |
| EP-1582560-A1 | Method and derived product, for the preparation of chips, flakes, pastes, and similar items, containing particles, to be added to moulding polymers and paints | Supercolori S.p.A. (IT) | 2005-10-05 | — | — | EP | claimed |
| US-20030091520-A1 | Use of at least one polar additive in a cosmetic composition comprising a liquid fatty phase structured by at least one molecular organogelator, to impart a thixotropic character to the composition | L'OREAL (FR) | 2003-05-15 | — | — | US | claimed |
| EP-1207918-A1 | METHOD OF TREATING BONE FOR IMPLANTATION AND RESULTING BONE | Osteotech, Inc., (US) | 2002-05-29 | — | — | EP | claimed |
| WO-2001013971-A1 | METHOD OF TREATING BONE FOR IMPLANTATION AND RESULTING BONE | OSTEOTECH, INC. (US) | 2001-03-01 | — | — | WO | claimed |
| US-6162258-A | Lyophilized monolithic bone implant and method for treating bone | OSTEOTECH, INC. (US) | 2000-12-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030091520-A1 | Use of at least one polar additive in a cosmetic composition comprising a liquid fatty phase structured by at least one molecular organogelator, to impart a thixotropic character to the composition | PLIN3, CUTA, FABP4 | CPB2 4673/4885CA2 4672/4885ZDHHC7 377/4885 |
| US-20090131542-A1 | Emulsifier Combination, Emulsion Containing the Emulsifier Combination, and a Process for its Production | GLUL, MOGAT2, AGXT | CPB2 1568/4885CA2 2344/4885ZDHHC7 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.